# Alexion Pharmaceuticals, Inc. – FDA Inspection, Jul 21, 2017

Source: https://www.keypedia.com/records/fda_inspections/alexion-pharmaceuticals-inc/98141ff0-1eb5-4854-b322-21be7b525527
Source feed: FDA_Inspections

> FDA inspection 1019062 of Alexion Pharmaceuticals, Inc., July 21, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1019062
- Company Name: Alexion Pharmaceuticals, Inc.
- Inspection Date: 2017-07-21
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 984855 - 2016-08-03
- FDA Inspection 938440 - 2015-08-12
- [FDA Inspection 892913 - 2014-08-22](https://www.keypedia.com/records/fda_inspections/alexion-pharmaceuticals-inc/1fe0988b-1aa2-498c-a4f8-2a4f55398a0c)
- FDA Inspection 710477 - 2011-02-18

## Related Officers

- [Company Rep](https://www.keypedia.com/people/jose-o-hernandez/960bffbe-1b8e-41bc-b203-aee88d7d8dac)
- [Nealie C. Newberger](https://www.keypedia.com/people/nealie-c-newberger/4b7addde-1217-4495-bac2-2f7e3fe2e780)

Company: https://www.keypedia.com/companies/alexion-pharmaceuticals-inc/125aa236-9807-4c76-8057-c66765afea64

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c